---
title: Bill Anderson
created-on: 2024-01-05T16:28:25.871Z
updated-on: 2024-01-05T16:28:25.877Z
published-on: 2024-01-05T16:28:25.883Z
f_organization: Bayer
f_title: CEO
f_headshot:
  url: /assets/images/bill-anderson.png
f_bio: William N. (Bill) Anderson has been a member of the Board of Management
  of Bayer AG since April 1, 2023. He became Chairman of the Board of Management
  (CEO) of Bayer AG on June 1, 2023.   Bill Anderson was born on August 23, 1966
  in Ohio, Texas, USA. He holds a Bachelor of Science degree from the University
  of Texas and a Master of Science degree from the Massachusetts Institute of
  Technology (MIT), both in Chemical Engineering. He also holds a Master of
  Science in Management from MIT’s Sloan School.   Bill started his professional
  career in 1989 at Ethyl Corporation, a U.S.-based specialty chemical company,
  with postings in Belgium and the Netherlands. In 1995, he joined Raychem
  Corporation, a U.S.-based material science and electronics firm. In 1997, Bill
  moved to Biogen, an American biotechnology firm, as a finance manager. He then
  became GM of the UK affiliate and eventually Vice President of Biogen’s
  Neurology Unit. Bill joined Genentech, a pioneering biotechnology company, in
  2006, eventually serving as Senior Vice President of the firm’s oncology
  business.   In 2013, he joined Roche Pharmaceuticals, the parent company of
  Genentech, as Head of Global Product Strategy and Chief Marketing Officer. In
  2016, he moved back to Genentech to assume the position of Head of North
  American Operations before becoming CEO of the company in 2017. In 2019, Bill
  became CEO of Roche Pharmaceuticals based in Switzerland.
f_vip: false
f_vvip: false
f_vvvip-1: false
tags: davos-speakers
layout: "[davos-speakers].html"
date: 2024-01-05T16:28:25.889Z
seo:
  noindex: false
  twitter:title: summary
  twitter:card: summary
---
